J. Vialaret

发表

Coordinated Post-translational Responses of Aquaporins to Abiotic and Nutritional Stimuli in Arabidopsis Roots*

C. Maurel, V. Santoni, M. di Pietro, 2013, Molecular & Cellular Proteomics.

Deciphering Black Extrinsic Tooth Stain Composition in Children Using Metaproteomics

S. Lehmann, P. Tramini, J. Armengaud, 2022, ACS omega.

Intact Protein Analysis by LC-MS for Characterizing Biomarkers in Cerebrospinal Fluid.

S. Lehmann, J. Vialaret, C. Hirtz, 2019, Methods in molecular biology.

Current and future use of “dried blood spot” analyses in clinical chemistry

S. Lehmann, J. Vialaret, C. Hirtz, 2013, Clinical chemistry and laboratory medicine.

Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer’s disease: Where do we stand?

S. Lehmann, A. Lleó, J. Vialaret, 2019, Critical reviews in clinical laboratory sciences.

Intra-articular delivery of full-length antibodies through the use of an in situ forming depot.

S. Grizot, J. Vialaret, C. Jorgensen, 2021, Journal of controlled release : official journal of the Controlled Release Society.

Proteomic profile of cerebrospinal fluid in patients with multiple sclerosis using two dimensional gel electrophoresis

S. Lehmann, J. Vialaret, C. Hirtz, 2016, British journal of biomedical science.

Assessing a multiplex-targeted proteomics approach for the clinical diagnosis of periodontitis using saliva samples.

S. Lehmann, J. Vialaret, C. Hirtz, 2018, Bioanalysis.

Proteomics Challenges for the Assessment of Synuclein Proteoforms as Clinical Biomarkers in Parkinson’s Disease

S. Lehmann, J. Vialaret, C. Hirtz, 2022, Frontiers in Aging Neuroscience.

Validation of a nanoliquid chromatography-tandem mass spectrometry method for the identification and the accurate quantification by isotopic dilution of glutathionylated and cysteinylated precursors of 3-mercaptohexan-1-ol and 4-mercapto-4-methylpentan-2-one in white grape juices.

A. Razungles, M. Moniatte, J. Vialaret, 2010, Journal of chromatography. A.

Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology

S. Lehmann, J. Vialaret, C. Hirtz, 2021, Critical reviews in clinical laboratory sciences.

Towards a routine application of Top-Down approaches for label-free discovery workflows.

Rainer Paape, D. Suckau, S. Lehmann, 2017, Journal of proteomics.

Comparison of Hydrophobic, Lipophilic and Immunodepletion Pre-Fractionation Methods for Label-Free LC-MS/MS Identification ofBiomarkers in Human Cerebrospinal Fluid

S. Lehmann, A. Gabelle, J. Vialaret, 2014 .

Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing.

S. Lehmann, A. Gabelle, J. Vialaret, 2016, Clinica chimica acta; international journal of clinical chemistry.

Regulatory context and validation of assays for clinical mass spectrometry proteomics (cMSP) methods

P. Lescuyer, S. Lehmann, J. Vialaret, 2018, Critical reviews in clinical laboratory sciences.

Rheology predicts sputum eosinophilia in patients with muco-obstructive lung diseases.

É. Matzner-Lober, J. Vialaret, I. Vachier, 2022, Biochemical and biophysical research communications.

Analytical comparison of ELISA and mass spectrometry for quantification of serum hepcidin in critically ill patients.

S. Lehmann, T. Lefèbvre, H. Puy, 2021, Bioanalysis.

A single short reprogramming early in life initiates and propagates an epigenetically related mechanism improving fitness and promoting an increased healthy lifespan

F. Casas, J. Vialaret, C. Jorgensen, 2022, Aging cell.

2nd EURO GEROSCIENCE Conference Oral Communications

J. Vialaret, C. Jorgensen, J. Lemaître, 2022, The journal of nutrition, health & aging.

The alternative proteome in neurobiology

X. Roucou, S. Lehmann, J. Vialaret, 2022, Frontiers in Cellular Neuroscience.

β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease

S. Lehmann, J. Vialaret, C. Hirtz, 2022, Alzheimer's Research & Therapy.

Nano-flow vs standard-flow: Which is the more suitable LC/MS method for quantifying hepcidin-25 in human serum in routine clinical settings?

S. Lehmann, J. Vialaret, C. Hirtz, 2018, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Laccases 2 & 3 as biomarkers of Botrytis cinerea infection in sweet white wines.

J. Vialaret, C. Hirtz, A. Attinà, 2020, Food chemistry.

Evolution of S-cysteinylated and S-glutathionylated thiol precursors during oxidation of Melon B. and Sauvignon blanc musts.

A. Razungles, J. Vialaret, A. Roland, 2010, Journal of agricultural and food chemistry.

Absolute quantification of 35 plasma biomarkers in human saliva using targeted MS.

S. Lehmann, A. Gabelle, J. Vialaret, 2016, Bioanalysis.

Hepcidin and ferritin levels in restless legs syndrome: a case–control study

S. Lehmann, I. Jaussent, Y. Dauvilliers, 2020, Scientific Reports.

Association between serum hepcidin level and restless legs syndrome

S. Lehmann, I. Jaussent, Y. Dauvilliers, 2018, Movement disorders : official journal of the Movement Disorder Society.

In Vivo Large Scale Mapping Of Protein Turnover In The Human Cerebrospinal Fluid

S. Lehmann, J. Colinge, O. Hanon, 2019, bioRxiv.

Arabidopsis thaliana High-Affinity Phosphate Transporters Exhibit Multiple Levels of Posttranslational Regulation[C][W]

C. Nespoulous, J. Vialaret, M. Rossignol, 2011, Plant Cell.

Stable Isotope Labeling by Amino acid in Vivo (SILAV): a new method to explore protein metabolism.

S. Lehmann, O. Hanon, A. Gabelle, 2015, Rapid communications in mass spectrometry : RCM.

Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications

S. Lehmann, A. Gabelle, J. Vialaret, 2015, Clinical chemistry and laboratory medicine.

FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell

Eric Rivals, E. Crapez, J. Vialaret, 2020, Nature Communications.

Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process

P. Robert, S. Lehmann, I. Jaussent, 2017, Neurobiology of Aging.

Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity.

L. Buée, S. Lehmann, C. Junot, 2016, Journal of proteome research.

Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry

S. Lehmann, A. Gabelle, J. Vialaret, 2015, Front. Neurosci..

Comparison of ultrasensitive and mass spectrometry quantification of blood-based amyloid biomarkers for Alzheimer’s disease diagnosis in a memory clinic cohort

S. Lehmann, K. Bennys, S. Lista, 2023, Alzheimer's Research & Therapy.

Variation of human salivary alpha-amylase proteoforms in three stimulation models

S. Lehmann, J. Vialaret, J. Cerón, 2019, Clinical Oral Investigations.

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.

L. Buée, S. Lehmann, C. Junot, 2016, Journal of Alzheimer's disease : JAD.

Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals

S. Lehmann, J. Laplanche, A. Lleó, 2020, medRxiv.

Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application

D. Hochstrasser, S. Lehmann, C. Lenz, 2013, Clinical chemistry and laboratory medicine.

Impact of biological matrix on inflammatory protein biomarker quantification based on targeted mass spectrometry.

S. Lehmann, J. Vialaret, C. Hirtz, 2018, Bioanalysis.

Regulation of glutamate metabolism by protein kinases in mycobacteria

P. Alzari, J. Vialaret, K. Johnsson, 2008, Molecular microbiology.

A single short reprogramming early in life improves fitness and increases lifespan in old age

F. Casas, J. Vialaret, C. Jorgensen, 2021, bioRxiv.

Phosphorylation dynamics of membrane proteins from Arabidopsis roots submitted to salt stress

C. Maurel, V. Santoni, M. di Pietro, 2014, Proteomics.

Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles

K. Blennow, S. Lehmann, A. Lleó, 2022, Journal of Neural Transmission.

Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias

K. Blennow, S. Lehmann, J. Clarimón, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid

S. Lehmann, Y. Dauvilliers, A. Gabelle, 2016, Scientific Reports.

Clinical perspectives of dried blood spot protein quantification using mass spectrometry methods

S. Lehmann, J. Vialaret, C. Hirtz, 2017, Critical reviews in clinical laboratory sciences.

Clinical measurement of Hepcidin-25 in human serum: Is quantitative mass spectrometry up to the job?

S. Lehmann, T. Lefèbvre, H. Puy, 2014 .

Hepcidin and ferritin levels in restless legs syndrome: a case–control study

S. Lehmann, I. Jaussent, Y. Dauvilliers, 2020, Scientific Reports.

Data from a targeted proteomics approach to discover biomarkers in saliva for the clinical diagnosis of periodontitis

S. Lehmann, J. Vialaret, C. Hirtz, 2018, Data in Brief.

Clinical mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold?

P. Lescuyer, S. Lehmann, J. Vialaret, 2017, Clinica chimica acta; international journal of clinical chemistry.

Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid

S. Lehmann, A. Gabelle, J. Vialaret, 2014, Clinical chemistry and laboratory medicine.

Immunoassay and Mass Spectrometry Methods for Tau Protein Quantification in the Cerebrospinal Fluid

S. Lehmann, A. Gabelle, J. Vialaret, 2021 .

The calcium-dependent protein kinase CPK7 acts on root hydraulic conductivity.

Marie Boudsocq, C. Maurel, V. Santoni, 2015, Plant, cell & environment.

Multiplexed LC-MS/MS quantification of salivary RNA modifications in periodontitis.

S. Lehmann, J. Vialaret, C. Hirtz, 2023, Journal of periodontal research.

Quantification of hepcidin-25 in human cerebrospinal fluid using LC-MS/MS.

S. Lehmann, A. Gabelle, J. Vialaret, 2017, Bioanalysis.

What sample preparation should be chosen for targeted MS monoclonal antibody quantification in human serum?

S. Lehmann, S. Broutin, A. Paci, 2018, Bioanalysis.

Clinical mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold?

P. Lescuyer, S. Lehmann, J. Vialaret, 2017, Clinica chimica acta; international journal of clinical chemistry.

IN VIVO LARGE SCALE MAPPING OF PROTEIN TURNOVER IN THE HUMAN CEREBROSPINAL FLUID.

S. Lehmann, A. Gabelle, J. Vialaret, 2019, Analytical chemistry.

Determination of plasma concentration of Belimumab by LC-MS/MS: Method development, validation, and clinical application.

J. Vialaret, C. Hirtz, M. Antignac, 2023, Journal of pharmaceutical and biomedical analysis.

New Perspectives of Multiplex Mass Spectrometry Blood Protein Quantification on Microsamples in Biological Monitoring of Elderly Patients

S. Lehmann, J. Vialaret, J. Cristol, 2023, International journal of molecular sciences.

A sensitive high-resolution mass spectrometry method for quantifying intact M-protein light chains in patients with multiple myeloma.

J. Vialaret, C. Hirtz, Stéphane Muccio, 2023, Clinica chimica acta; international journal of clinical chemistry.

Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells.

J. Vialaret, C. Hirtz, C. Alix-Panabières, 2024, Molecular oncology.